NCT01102465View on ClinicalTrials.gov

Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions

Hypertension

Interventions

DRUG

losartan potassium hydrochlorothiazide

100 mg / 25 mg tablet

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

All Listed Sponsors

lead

Roxane Laboratories

INDUSTRY

NCT01102465 - Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions | Biotech Hunter | Biotech Hunter